KP Tissue (TSE:KPT) Price Target Raised to C$14.00

KP Tissue (TSE:KPT) had its target price upped by stock analysts at TD from C$12.00 to C$14.00 in a report issued on Tuesday,BayStreet.CA reports. The brokerage currently has a “hold” rating on the stock. TD’s target price points to a potential upside of 8.11% from the company’s previous close.

Separately, Desjardins raised their price target on KP Tissue from C$12.00 to C$12.50 and gave the stock a “hold” rating in a report on Friday, May 15th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of C$12.12.

KP Tissue Trading Down 0.4%

Shares of TSE KPT traded down C$0.05 during midday trading on Tuesday, hitting C$12.95. The company’s stock had a trading volume of 12,947 shares, compared to its average volume of 15,757. The firm has a market capitalization of C$129.86 million, a price-to-earnings ratio of 14.39, a P/E/G ratio of -0.88 and a beta of 0.53. The stock has a fifty day moving average price of C$12.56 and a 200 day moving average price of C$11.35. KP Tissue has a one year low of C$8.77 and a one year high of C$13.78.

KP Tissue (TSE:KPT) last released its quarterly earnings data on Thursday, May 14th. The company reported C$0.22 earnings per share for the quarter. On average, equities research analysts predict that KP Tissue will post 0.4398964 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director David A. Spraley sold 3,668 shares of the business’s stock in a transaction on Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the completion of the transaction, the director directly owned 15,712 shares in the company, valued at C$208,969.60. The trade was a 18.93% decrease in their position. Over the last ninety days, insiders have sold 6,668 shares of company stock valued at $87,644. 0.14% of the stock is owned by company insiders.

KP Tissue Company Profile

KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.